dronabinol has been researched along with Pain in 207 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (10.63) | 18.7374 |
| 1990's | 12 (5.80) | 18.2507 |
| 2000's | 79 (38.16) | 29.6817 |
| 2010's | 61 (29.47) | 24.3611 |
| 2020's | 33 (15.94) | 2.80 |
| Authors | Studies |
|---|---|
| Harbert, CA; Johnson, MR; Melvin, LS; Milne, GM; Weissman, A | 1 |
| Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D | 1 |
| Cheng, YX; Lessard, E; Luo, X; Payza, K; Pourashraf, M; Salois, D; Srivastava, S; St-Onge, S; Tomaszewski, MJ; Walpole, C; Yu, XH | 1 |
| Mowrey, DD; Sun, T; Tang, P; Tillman, TS; Wells, MM; Xu, Y | 1 |
| Lou, K; Murphy, S; Talbot, C | 1 |
| Burr, JF; Cheung, CP; Close, GL; Gillham, SH; Kasper, AM | 1 |
| Britch, SC; Craft, RM | 1 |
| Moore, CF; Weerts, EM | 1 |
| Craft, RM; Gogulski, HY | 1 |
| Bruno, R; Copeland, J; Dunlop, A; Jackson, MA; Jefferies, M; Lintzeris, N; McGregor, I; Mills, L; Montebello, M; Rivas, C; Silsbury, C | 1 |
| Chisari, CG; Fernández, Ó; Ferrer-Picón, E; Hernández Vicente, F; Patti, F; Sarroca, J; Vila Silván, C | 1 |
| Brens, J; Korenstein, D; Li, QS; Mao, JJ; Raghunathan, NJ; Vemuri, S | 1 |
| Aprikian, S; Canac-Marquis, M; Kasvis, P; Vigano, A; Vigano, M | 1 |
| Attwood, K; Case, AA; Elibol, J; Hansen, ED; Hyland, A; Mupamombe, CT; Nathan, R; Smith, D | 1 |
| Bruno, R; Copeland, J; Dunlop, A; Jefferies, M; Lintzeris, N; Mcgregor, I; Mills, L; Montebello, M | 1 |
| Green, R; Khalil, R; Mohapatra, S; Mohapatra, SS | 1 |
| Mantri, N; Reddy, TS; Zomer, R | 1 |
| Canseco-Alba, A; Castillo-Arellano, J; Cutler, SJ; León, F | 1 |
| Antunes, FTT; Gadotti, VM; Zamponi, GW | 1 |
| Filip, M; Frankowska, M; Furgała-Wojas, A; Gawliński, D; Kieć-Kononowicz, K; Kotańska, M; Miszkiel, J; Müller, CE; Sałat, K; Suder, A; Wydra, K; Zaniewska, M | 1 |
| Barré, T; Carrieri, P; Marcellin, F; Protopopescu, C; Radoszycki, L; Ramier, C; Roux, P; Santos, M; Testa, D | 1 |
| Compton, P; De Aquino, JP; Meyerovich, J; Pittman, B; Ranganathan, M; Rogan, M; Sofuoglu, M; Xie, CZ | 1 |
| Lee, M; Munjal, V; Shahzad, H; Veliky, C; Yu, E | 1 |
| Gastmeier, K; Wendelmuth, C | 1 |
| Gastmeier, A; Gastmeier, K; Torontali, M; Wendelmuth, C; Wirz, S | 1 |
| Goggin, MM; Janis, GC; Shahriar, BJ; Stead, A | 1 |
| Brockelman, F; Hall, B; Keeling, K; Li, X; Stith, SS; Vigil, JM | 1 |
| Arriaga-Gomez, E; Boo, B; Bush, S; Chatterjea, D; Emanuel, E; Kinnamon, R; Kline, J; Lim, J; Mengistu, H; Neamonitaki, N; Pasha, D; Shields-Cutler, R; Wattenberg, E; Yangdon, T; Zacheis, H | 1 |
| Argerich, J; Cabañero, D; Escudero-Lara, A; Maldonado, R | 1 |
| Highet, BH; Johnson, PW; Kaur, JS; Lesser, ER | 1 |
| Clauw, DJ; Fitzcharles, MA; Häuser, W | 1 |
| Alton, K; Bayer, LL; Beardsworth, K; Bednarek, PH; Colwill, AC; Edelman, A; Garg, B; Jensen, JT | 1 |
| Carra, A; Fragoso, YD; Macias, MA | 1 |
| D'Souza, DC; DeForest, A; Perrino, A; Pittman, BP; Ranganathan, M; Schindler, EAD; Schnakenberg Martin, AM; Sewell, RA | 1 |
| Cantello, R; Naldi, P; Spagarino, A; Varrasi, C; Vecchio, D; Virgilio, E | 1 |
| Le Foll, B | 1 |
| Bhattacharyya, S; McGoohan, KL; Velayudhan, L | 1 |
| Ataiants, J; Conn, BM; Fedorova, EV; Iverson, E; Lankenau, SE; Wong, CF | 1 |
| Budde, H; Coronado-Álvarez, A; Imperatori, C; Machado, S; Macías-Triana, L; Murillo-Rodríguez, E; Romero-Cordero, K; Tatum-Kuri, A; Vera-Barrón, A; Yamamoto, T | 1 |
| Bergeria, CL; Campbell, CM; Dunn, KE; Huhn, AS; Mun, CJ; Speed, TJ; Vandrey, R | 1 |
| Bladen, C; Connor, M; Mirlohi, S; Santiago, M | 1 |
| Creehan, KM; Gutierrez, A; Kerr, TM; Nguyen, JD; Taffe, MA; Tran, RN; Turner, ML | 1 |
| Craft, RM; Greene, NZ; Wakley, AA | 1 |
| Achenbach, JC; Berrue, F; Ellis, LD; Hill, J; McDougall, JJ; Morash, M | 1 |
| Bowen, LL; McRae-Clark, AL | 1 |
| MacCallum, CA; Russo, EB | 1 |
| Buckley, N; Degenhardt, L; Farrell, M; Germanos, R; Hall, W; Nielsen, S; Pollard, J; Weier, M | 1 |
| Henderson-Redmond, AN; LaFleur, RA; Morgan, DJ; Wilson, RP | 1 |
| Dawson, CT; Hilgendorf, TN; Kandasamy, R; Morgan, MM | 1 |
| de Kam, ML; Groeneveld, GJ; Hay, JL; Siebenga, P; van Amerongen, G | 1 |
| Limebeer, CL; Parker, LA; Rock, EM | 1 |
| Duipmans, JC; Jonkman, MF; Molenbuur, B; Schräder, NHB; Wolff, AP | 1 |
| Martinez, AE | 1 |
| Britch, SC; Buzitis, NW; Clowers, BH; Craft, RM | 1 |
| Arbus, MS; Beliveau, JN; Casarett, DJ | 1 |
| Florek, E; Piekoszewski, W; Tkaczyk, M | 1 |
| Boscá Blasco, I; Casanova-Estruch, B; Escutia Roig, M; Gil Gómez, I; Lorente Fernández, L; Monte Boquet, E; Pérez-Miralles, F; Poveda Andrés, JL | 1 |
| Kohnz, RA; Nomura, DK | 1 |
| Benyamina, A; Reynaud, M | 1 |
| Lötsch, J; Oertel, BG; Walter, C | 1 |
| Kramer, JL | 1 |
| Bugaj, B; Cabała, K; Pypno, D; Waracki, M; Zdrojewicz, Z | 1 |
| Bashashati, M; Eno, MR; Hu, H; Keenan, CM; Mackie, K; Makriyannis, A; Nikas, SP; Sharkey, KA; Storr, MA; Straiker, A; Thakur, GA; Wager-Miller, J; Wood, JT | 1 |
| Côté, M; Fortin, A; Trudel, M; Wang, C | 1 |
| Deichmann, R; Felden, L; Kaiser, J; Kell, CA; Lötsch, J; Nöth, U; Oertel, BG; Vermehren, J; Walter, C | 1 |
| Ablin, J; Fitzcharles, MA; Häuser, W; Schäfer, M; Ste-Marie, PA | 1 |
| Radbruch, L; Schäfer, M | 1 |
| Giudice, MG; Tsang, CC | 1 |
| Ciccone, CD | 1 |
| Aragona, M; Bettolo, CM; Conte, A; Frasca, V; Gabriele, M; Giacomelli, E; Gilio, F; Iacovelli, E; Inghilleri, M; Onesti, E; Pantano, P; Pozzilli, C; Tomassini, V | 1 |
| Ashton, J | 1 |
| Kinsey, SG; Lichtman, AH; Schlosburg, JE | 1 |
| Bereza, B; Desjardins, O; Einarson, TR; Iskedjian, M; Jaszewski, B; Piwko, C | 1 |
| Crestani, F; Piva, B; Shaladi, AM; Tartari, S | 1 |
| Annas, P; Deeprose, C; Edgar, CJ; Kalliomäki, J; Karlsten, R; Philipp, A; Segerdahl, M; Wesnes, KA | 1 |
| Booker, L; Lichtman, AH; Mahadevan, A; Naidu, PS; Razdan, RK | 1 |
| Bari, M; Battistini, L; Bernardi, G; Buttari, F; Cencioni, MT; Centonze, D; Codecà, C; Fiore, S; Koch, G; Maccarrone, M; Mori, F; Rossi, S | 1 |
| Emery, CJ; Gandhi, R; Selvarajah, D; Tesfaye, S | 1 |
| Esfahani, F; Frost, E; Gomori, A; Le Dorze, JA; Namaka, M; Turcotte, D | 1 |
| Casu, GL; Fadda, P; Lazzari, P; Marchese, G; Pani, L | 1 |
| Bolognini, D; Cascio, MG; Comelli, F; Costa, B; Di Marzo, V; Gauson, LA; Maione, S; Marini, P; Parolaro, D; Pertwee, RG; Ross, RA | 1 |
| Craft, RM; Wakley, AA | 2 |
| Gross, H | 1 |
| Conrad, DH; Lichtman, AH; O'Neal, ST; Schlosburg, JE | 1 |
| de la Torre, R; Huestis, MA; Kwong, TC; Morland, J; Verstraete, A; Vincent, MJ | 1 |
| Christie, MJ; Vaughan, CW | 2 |
| Binswanger, I; Nussbaum, A; Thurstone, C | 1 |
| Ashton, CH; Moore, PB | 1 |
| Annas, P; Baxendale, J; Kalliomäki, J; Karlsten, R; Philipp, A; Segerdahl, M | 1 |
| Brower, V | 1 |
| Guindon, J | 1 |
| Beijnen, JH; Brandsma, D; Huitema, AD; Schellens, JH; van den Heuvel, MM; van Hasselt, JG | 1 |
| Beumer, TL; de Kam, ML; Freijer, JI; Karger, LB; Kleinloog, HD; Klumpers, LE; Lipplaa, A; van Gerven, JM; van Hasselt, JG | 1 |
| Gabler, M; Schubert-Zsilavecz, M | 1 |
| Barnes, D; Hobart, JC; Mattison, PG; Slade, A; Zajicek, JP | 1 |
| Lamarine, RJ | 1 |
| Kwilasz, AJ; Negus, SS | 1 |
| Constantinescu, CS; Podda, G | 1 |
| Pertwee, RG | 1 |
| Borgelt, LM; Franson, KL; Nussbaum, AM; Wang, GS | 1 |
| Smith, PF | 2 |
| Dey, SK; Hough, LB; Leurs, R; Nalwalk, JW; Paria, BC; Stadel, R; Timmerman, H; Wang, X | 1 |
| Anikwue, R; Huffman, JW; Martin, ZL; Welch, SP | 1 |
| Gardell, LR; Lai, J; Ossipov, MH; Porreca, F; Vanderah, TW | 1 |
| Atlani, S; Attal, N; Brasseur, L; Clermont-Gnamien, S; Guirimand, F; Le Mercier, F | 1 |
| Cichewicz, DL; McCarthy, EA | 1 |
| Aram, J; House, H; Makela, P; Robson, P; Wade, DT | 1 |
| Beckett, SR; Chapman, V; Finn, DP; Jhaveri, MD; Kendall, DA; Marsden, CA; Roe, CH | 1 |
| Arendt-Nielsen, L; Brenneisen, R; Curatolo, M; Naef, M; Petersen-Felix, S; Zbinden, A | 1 |
| Burstein, S; Conrad, I; Hoy, L; Karst, M; Salim, K; Schneider, U | 1 |
| Brown, SC; Jeavons, M; Rudich, Z; Stinson, J | 1 |
| Beckett, SR; Chapman, V; Finn, DP; Fone, KC; Kendall, DA; Madjd, A; Marsden, CA; Roe, CH | 1 |
| Capellà, D; Duran, M; Laporte, JR | 1 |
| Szendrei, K | 1 |
| Miller, R; Newport, S; Notcutt, W; Phillips, C; Price, M; Sansom, C; Simmons, S | 1 |
| Cox, ML; Welch, SP | 1 |
| Burstein, SH; Karst, M; Schneider, U; Zurier, RB | 1 |
| Bach, FW; Jensen, TS; Svendsen, KB | 2 |
| Bateman, C; House, H; Makela, P; Robson, P; Wade, DT | 1 |
| Berman, JS; Birch, R; Symonds, C | 1 |
| Burstein, S; Zurier, RB | 1 |
| Alger, BE; Nicoll, RA | 1 |
| Lutz, B; Monory, K | 1 |
| Berger, T; Bodner, T; Entner, T; Fleischhacker, WW; Kemmler, G; Kurzthaler, I; Wissel, J | 1 |
| Brain, C; Chen, A; Courade, JP; Dyson, A; Fox, A; Groarke, A; Loong, Y; Peacock, M; Yaqoob, M | 1 |
| Blake, DR; Ho, M; Jubb, RW; McCabe, CS; Robson, P | 1 |
| Gennings, C; Roberts, JD; Shih, M | 1 |
| Barnes, MP | 1 |
| Guy, G; Ware, M; Wright, S | 1 |
| Brandon, DE; Cash, KA; Damron, KS; Manchikanti, L; Manchukonda, R; McManus, CD; Pampati, V | 1 |
| Konrad, C; Legler, A; Rukwied, R; Schley, M; Schmelz, M; Skopp, G | 1 |
| Hiermann, E; Pinsger, M; Pölz, W; Riederer, F; Schimetta, W; Volc, D | 1 |
| Cichewicz, DL; Haller, VL; Welch, SP | 1 |
| Berger, T; Brenneis, C; Haydn, T; Müller, J; Poewe, W; Schelosky, LD; Wissel, J | 1 |
| Hough, LB; Nalwalk, JW; Svokos, K | 1 |
| Berger, JM; Brenneisen, R; Ghafoor, N; Grotenhermen, F; Hagenbach, U; Luz, S; Mäder, M | 1 |
| Daeninck, P; Davis, M; Maida, V; Pergolizzi, J | 1 |
| D'Arcy, Y | 2 |
| Baxter, K; Burton, D; Busciglio, I; Camilleri, M; Esfandyari, T; Zinsmeister, AR | 1 |
| Agarwal, N; Bátkai, S; Bergmann, F; Friess, H; Giese, NA; Giese, T; Kuner, R; Laukert, T; Michalski, CW; Pacher, P; Sauliunaite, D; Su, Y | 1 |
| Wallace, JM | 1 |
| Cox, ML; Haller, VL; Welch, SP | 1 |
| Selley, DE; Sim-Selley, LJ; Smith, PA; Welch, SP | 1 |
| Scully, C | 1 |
| Guy, GW; Robson, PJ; Russo, EB | 1 |
| Beaulieu, P; Ware, M | 1 |
| Craft, RM; Leitl, MD | 1 |
| Ethans, K; Galimova, L; Perry, D; Skrabek, RQ | 1 |
| Nurmikko, TJ; Rog, DJ; Young, CA | 1 |
| Abramson, I; Atkinson, JH; Bentley, H; Gouaux, B; Lazzaretto, D; Schulteis, G; Wallace, M; Wolfson, T | 1 |
| Gibson, D; Jamison, RN; Michna, E; Narang, S; Nedeljkovic, SS; Ross, EL; Wasan, AD | 1 |
| Davis, MP | 1 |
| Frank, B; Hughes, J; Kapur, D; Matthews, JN; Serpell, MG | 1 |
| Goffaux, P; Marchand, S; Potvin, S; Redmond, WJ | 1 |
| Ernst, G; Kongsgaard, UE | 1 |
| Bonsignore, A; Grossi, S; Martelli, A; Molinelli, A | 1 |
| Johnson, RL; Moss, DE | 1 |
| Cohen, S | 2 |
| Melvin, LS; Milne, GM; Weissman, A | 1 |
| Doyle, E; Spence, AA | 1 |
| Abood, ME; Pugh, G; Welch, SP | 1 |
| Balster, RL; Compton, DR; Dutta, A; Gordon, PM; Lichtman, AH; Martin, BR; Razdan, RK; Siegel, C; Singer, M; Wiley, JL | 1 |
| Burstein, SH; Friderichs, E; Kögel, B; Schneider, J; Selve, N | 1 |
| Duncan, SG; Huffman, JW; Liddle, J; Martin, BR; Wiley, JL; Yu, S | 1 |
| Lichtman, AH; Martin, BR | 1 |
| di Vadi, PP; Hamann, W | 1 |
| Lowe, J; Mason, DJ; Welch, SP | 1 |
| Carta, G; Gessa, GL; Nava, F | 1 |
| Eads, M; Embrey, JP; Houser, SJ; Welch, SP | 1 |
| Crocker, PC; Martin, BR; Patrick, GS; Razdan, RK; Saha, B; Wiley, JL | 1 |
| Bridgen, DT; Byron, PR; Lichtman, AH; Martin, BR; Meng, Y; Peart, J; Poklis, A; Poklis, JL; Razdan, RK; Wilson, DM | 1 |
| Ates, M; Brune, K; Gühring, H; Hamza, M; Kotalla, CE; Schuster, J | 1 |
| Gurwitz, D; Weizman, A | 1 |
| Elsner, F; Radbruch, L; Sabatowski, R | 1 |
| Mechoulam, R; Panikashvili, D; Shohami, E | 1 |
| Bountra, C; Clayton, N; Marshall, FH; O'Shaughnessy, CT | 1 |
| Andersson, DA; Hogestatt, ED; Zygmunt, PM | 1 |
| Avery, DA; Brunk, SF; Canter, AC; Noyes, R | 1 |
| Gantt, C; Machin, D; Staquet, M | 1 |
| Chau-Pham, T; Dewey, WL; Martin, BR; Prnage, AJ | 1 |
| Bhargava, HN | 1 |
| Nightingale, SL; Perry, S | 1 |
| Ghia, J; Gregg, J; Harris, L; Raft, D | 1 |
| Gregg, JM; Moore, R; Raft, D; Small, EW; Toomey, TC | 1 |
| Karniol, IG; Knobel, E; Musty, RE; Shirakawa, I; Takahashi, RN | 1 |
| Chesher, GB; Jackson, DM; Starmer, GA; Welburn, PJ | 1 |
| Martin, BR; Smith, PB | 1 |
| Evans, FJ | 1 |
| Eisen, A; Feigenbaum, JJ; Mechoulam, R; Seltzer, Z; Zeltser, R | 1 |
| Burstein, SH; Hull, K; Hunter, SA; Latham, V | 1 |
| Andrysiak, T; Ungerleider, JT | 1 |
| Herring, BS; Webster, CD; Willinsky, MD | 1 |
| Anderson, JE; Goldberg, ME; Hefner, MA; Robichaud, RC | 1 |
| Goodwin, DW; Hill, SY; Powell, B; Schwin, R | 1 |
| Buxbaum, DM | 1 |
| Dewey, WL; Harris, LS; Kennedy, JS | 1 |
44 review(s) available for dronabinol and Pain
| Article | Year |
|---|---|
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels | 2010 |
Cannabis and Athletic Performance.
Topics: Athletic Performance; Cannabidiol; Cannabis; Dronabinol; Humans; Pain | 2021 |
Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges.
Topics: Animals; Cannabidiol; Dronabinol; Mice; Neoplasms; Pain; Quality of Life | 2022 |
Nanoformulations as a strategy to overcome the delivery limitations of cannabinoids.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Humans; Lipids; Pain | 2023 |
The Polypharmacological Effects of Cannabidiol.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Epilepsy; Humans; Pain | 2023 |
[Dronabinol in geriatric pain and palliative care patients : A retrospective evaluation of statutory-health-insurance-covered outpatient medical treatment].
Topics: Aged; Ambulatory Care; Cohort Studies; Dronabinol; Humans; Pain; Palliative Care; Retrospective Studies | 2019 |
Cautious Hope for Cannabidiol (CBD) in Rheumatology Care.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Pain; Rheumatology | 2023 |
Cannabis and multiple sclerosis.
Topics: Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Drug Combinations; Humans; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Pain; Urologic Diseases | 2020 |
Opioid-sparing effects of cannabinoids: Myth or reality?
Topics: Analgesics, Opioid; Animals; Cannabinoids; Clinical Trials as Topic; Dronabinol; Drug Evaluation, Preclinical; Drug Synergism; Humans; Morphine; Opioid-Related Disorders; Pain | 2021 |
Evaluation of THC-Related Neuropsychiatric Symptoms Among Adults Aged 50 Years and Older: A Systematic Review and Metaregression Analysis.
Topics: Aged; Anorexia; Antineoplastic Agents; Cancer Pain; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Dizziness; Dose-Response Relationship, Drug; Dronabinol; Humans; Middle Aged; Multiple Sclerosis; Nausea; Neurodegenerative Diseases; Pain; Perceptual Disorders; Randomized Controlled Trials as Topic; Regression Analysis; Self Report; Vomiting | 2021 |
The synthetic CB
Topics: Analgesics; Animals; Anti-Anxiety Agents; Cannabinoid Receptor Agonists; Cannabinoids; Controlled Substances; Cyclohexanols; Dronabinol; Humans; Mental Disorders; Pain; Phenanthridines; Receptor, Cannabinoid, CB1 | 2021 |
Therapeutic Benefit of Smoked Cannabis in Randomized Placebo-Controlled Studies.
Topics: Dronabinol; Humans; Intraocular Pressure; Marijuana Smoking; Medical Marijuana; Pain; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2018 |
Practical considerations in medical cannabis administration and dosing.
Topics: Cannabidiol; Cannabis; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Drug Combinations; Humans; Inflammation; Medical Marijuana; Pain | 2018 |
The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Pain; Quality of Life; Randomized Controlled Trials as Topic; Systematic Reviews as Topic | 2018 |
[Marihuana and cannobinoids as medicaments].
Topics: Arthritis, Rheumatoid; Cannabidiol; Cannabinoids; Cannabis; Contraindications; Dronabinol; Drug Combinations; Humans; Inflammatory Bowel Diseases; Multiple Sclerosis; Muscle Spasticity; Nausea; Nervous System Diseases; Pain; Plant Extracts; Vomiting | 2012 |
Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids.
Topics: Animals; Arachidonic Acids; Dronabinol; Eicosanoids; Endocannabinoids; Enzyme Inhibitors; Glycerides; Humans; Lipoprotein Lipase; Monoacylglycerol Lipases; Mood Disorders; Neoplasms; Neurodegenerative Diseases; Pain; Signal Transduction | 2014 |
Medical marijuana for cancer.
Topics: Analgesics, Non-Narcotic; Antiemetics; Canada; Cannabidiol; Clinical Trials as Topic; Dronabinol; Drug Combinations; Evidence-Based Medicine; Humans; Medical Marijuana; Multiple Sclerosis; Neoplasms; Pain; Treatment Outcome; United Kingdom; United States | 2015 |
[Potential applications of marijuana and cannabinoids in medicine].
Topics: Cannabinoids; Diabetes Mellitus; Dronabinol; Humans; Medical Marijuana; Neoplasms; Nervous System Diseases; Pain; Phytotherapy; Receptors, Cannabinoid; Vomiting | 2014 |
Nabilone for the Management of Pain.
Topics: Analgesics; Clinical Trials as Topic; Disease Management; Dronabinol; Humans; Pain; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Treatment Outcome | 2016 |
Medical Marijuana: Just the Beginning of a Long, Strange Trip?
Topics: Cannabidiol; Cognition Disorders; Confusion; Controlled Substances; Depression; Dronabinol; Drug Administration Routes; Hallucinations; Heart; Humans; Lung; Marijuana Abuse; Medical Marijuana; Memory Disorders; Muscle Spasticity; Nausea; Pain; Physical Therapists; Postural Balance; Professional Role; Vomiting | 2017 |
Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.
Topics: Amidohydrolases; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Disease Models, Animal; Dronabinol; Drug Delivery Systems; Drug Evaluation, Preclinical; Endocannabinoids; Glycerides; Humans; Inflammation; Mice; Mice, Knockout; Pain; Peroxisome Proliferator-Activated Receptors; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, Opioid; TRPV Cation Channels | 2009 |
[Cannabinoids in the control of pain].
Topics: Amino Acid Sequence; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Arachidonic Acids; Cachexia; Cannabinoids; Cannabis; Dronabinol; Endocannabinoids; Humans; Molecular Sequence Data; Nausea; Pain; Phytotherapy; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2008 |
Examining the roles of cannabinoids in pain and other therapeutic indications: a review.
Topics: Activities of Daily Living; Cannabinoids; Cannabis; Combined Modality Therapy; Double-Blind Method; Dronabinol; Humans; Hypersensitivity; Pain; Pain Measurement | 2010 |
Endocannabinoid system dysfunction in mood and related disorders.
Topics: Anxiety; Bipolar Disorder; Cannabidiol; Cannabinoid Receptor Modulators; Cannabinoids; Cerebral Cortex; Depression; Dronabinol; Electroencephalography; Endocannabinoids; Humans; Mood Disorders; Pain; Receptors, Cannabinoid; Schizophrenia; Suicide | 2011 |
Marijuana: modern medical chimaera.
Topics: Cannabinoids; Cannabis; Clinical Trials as Topic; Dronabinol; Humans; Marijuana Abuse; Muscle Spasticity; Nausea; Pain; Quality of Life; United States | 2012 |
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis.
Topics: Analgesics; Animals; Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Treatment Outcome; Urologic Diseases | 2012 |
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
Topics: Analgesics; Animals; Blood-Brain Barrier; Cannabinoid Receptor Agonists; Cardiovascular Diseases; Clinical Trials as Topic; Dronabinol; Drug Discovery; Endocannabinoids; Humans; Neurodegenerative Diseases; Pain; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Risk Assessment | 2012 |
The pharmacologic and clinical effects of medical cannabis.
Topics: Animals; Cannabis; Clinical Trials as Topic; Dronabinol; Humans; Pain; Phytotherapy; Receptor, Cannabinoid, CB1; Spasm; Treatment Outcome | 2013 |
Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
Topics: Analgesics, Non-Narcotic; Animals; Cannabinoid Receptor Modulators; Cannabinoids; Cannabis; Disease Models, Animal; Dronabinol; Fatty Acids, Unsaturated; Humans; Multiple Sclerosis; Muscle Weakness; Pain; Receptors, Cannabinoid; Receptors, Drug; Spasm | 2002 |
[News about therapeutic use of Cannabis and endocannabinoid system].
Topics: Cannabinoid Receptor Modulators; Cannabinoids; Cannabis; Dronabinol; Endocannabinoids; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Phytotherapy; Plant Extracts; Receptors, Cannabinoid | 2004 |
[A novel analgesics made from Cannabis].
Topics: Analgesics; Arachidonic Acids; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Drugs, Investigational; Endocannabinoids; Europe; Humans; Multiple Sclerosis; Pain; Plant Extracts; Polyunsaturated Alkamides | 2004 |
Ajulemic acid: A novel cannabinoid produces analgesia without a "high".
Topics: Analgesics; Anti-Inflammatory Agents; Cannabis; Dronabinol; Drug Design; Pain; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2004 |
Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain.
Topics: Analgesics; Cannabidiol; Cannabinoids; Dronabinol; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Phytotherapy; Plant Extracts; Randomized Controlled Trials as Topic; Self Administration; Sleep Wake Disorders | 2006 |
The emerging role of cannabinoid neuromodulators in symptom management.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Dronabinol; Female; Humans; Middle Aged; Pain; Receptors, Cannabinoid; Spinal Neoplasms; Vomiting | 2007 |
Latest pain relief a combination of new and old.
Topics: Cannabidiol; Carbazoles; Delayed-Action Preparations; Dronabinol; Drug Combinations; Humans; Nurse Practitioners; Pain; Plant Extracts; Serotonin Receptor Agonists; Tryptamines | 2007 |
Update on pharmacotherapy guidelines for treatment of neuropathic pain.
Topics: Analgesics; Animals; Cannabidiol; Chronic Disease; Dronabinol; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Guidelines as Topic; Humans; Pain; Peripheral Nervous System Diseases; Pregabalin; Thiophenes | 2007 |
Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.
Topics: Cannabidiol; Cannabis; Clinical Trials as Topic; Dronabinol; Drug Combinations; Humans; Pain; Phytotherapy; Plant Extracts; Plant Preparations; Sleep; Sleep Wake Disorders | 2007 |
Reassessment of the role of cannabinoids in the management of pain.
Topics: Acute Disease; Administration, Inhalation; Administration, Oral; Anti-Anxiety Agents; Cannabinoids; Chronic Disease; Dose-Response Relationship, Drug; Dronabinol; Humans; Pain; Pain Measurement | 2007 |
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Humans; Nausea; Pain; Treatment Outcome; Vomiting | 2008 |
[Use of cannabinoids in palliative medicine].
Topics: Analgesics, Non-Narcotic; Antiemetics; Appetite; Cannabinoids; Dronabinol; Humans; Nausea; Neuralgia; Pain; Palliative Care; Pruritus; Receptors, Cannabinoid | 2008 |
Marijuana research findings: 1980. Therapeutic aspects.
Topics: Animals; Asthma; Cannabis; Dronabinol; Epilepsy; Glaucoma; Humans; Nausea; Neoplasms; Pain | 1980 |
Cannabinoid transmission and pain perception.
Topics: Analgesics; Animals; Cannabinoids; Dronabinol; Humans; Pain; Receptors, Cannabinoid; Receptors, Drug; Synaptic Transmission | 1998 |
An analgesic role for cannabinoids.
Topics: Animals; Cannabinoids; Cannabis; Dronabinol; Humans; Marijuana Smoking; Pain | 2000 |
Cannabinoids: the separation of central from peripheral effects on a structural basis.
Topics: Animals; Cannabinoids; Central Nervous System; Dronabinol; Humans; Inflammation; Pain; Peripheral Nerves; Structure-Activity Relationship | 1991 |
44 trial(s) available for dronabinol and Pain
| Article | Year |
|---|---|
Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial.
Topics: Analgesics; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Comorbidity; Double-Blind Method; Dronabinol; Drug Combinations; Hallucinogens; Humans; Marijuana Abuse; Medical Marijuana; Pain; Sleep; Treatment Outcome | 2022 |
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder.
Topics: Australia; Bayes Theorem; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Humans; Male; Marijuana Abuse; Pain; Substance-Related Disorders | 2022 |
Delta-9-tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study.
Topics: Analgesics, Opioid; Dronabinol; Female; Humans; Male; Methadone; Opioid-Related Disorders; Pain | 2023 |
Cannabinoids for Pain Control During Medical Abortion: A Randomized Controlled Trial.
Topics: Abortion, Induced; Adult; Analgesics, Non-Narcotic; Double-Blind Method; Dronabinol; Female; Humans; Ibuprofen; Pain; Pain Management; Pregnancy; Young Adult | 2020 |
In an exploratory randomized, double-blind, placebo-controlled, cross-over study, psychoactive doses of intravenous delta-9-tetrahydrocannabinol fail to produce antinociceptive effects in healthy human volunteers.
Topics: Administration, Intravenous; Adult; Analgesics; Cannabinoids; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Euphoria; Female; Healthy Volunteers; Humans; Male; Pain; Pain Measurement; Psychotropic Drugs | 2020 |
Cannabinoids in multiple sclerosis: A neurophysiological analysis.
Topics: Administration, Oral; Adult; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Muscle Spasticity; Muscle, Skeletal; Pain; Pilot Projects; Treatment Outcome | 2020 |
Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model.
Topics: Adult; Analgesics, Opioid; Cannabinoids; Double-Blind Method; Dronabinol; Humans; Hydromorphone; Laboratories; Pain | 2021 |
Effect profile of paracetamol, Δ9-THC and promethazine using an evoked pain test battery in healthy subjects.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Allergic Agents; Attention; Cognition; Cold Temperature; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Healthy Volunteers; Humans; Male; Pain; Pain Measurement; Pain Threshold; Pressure; Promethazine; Young Adult | 2018 |
Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial.
Topics: Affect; Antiemetics; Appetite; Body Weight; Carcinoma, Squamous Cell; Chemoradiotherapy; Double-Blind Method; Dronabinol; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nausea; Pain; Pain Measurement; Quality of Life; Radiotherapy; Sleep; Squamous Cell Carcinoma of Head and Neck | 2016 |
Brain Mapping-Based Model of Δ(9)-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix.
Topics: Adult; Analgesics; Brain; Brain Mapping; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Functional Neuroimaging; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Models, Neurological; Neural Pathways; Pain; Somatosensory Cortex; Thalamus; Young Adult | 2016 |
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis.
Topics: Administration, Oral; Adult; Afferent Pathways; Analgesics; Cannabinoids; Central Nervous System; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Neural Conduction; Nociceptors; Pain; Pain Measurement; Pain Threshold; Placebos; Reaction Time; Reflex; Treatment Outcome | 2009 |
Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers.
Topics: Affect; Attention; Capsaicin; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Humans; Male; Memory; Memory, Short-Term; Mental Recall; Pain; Perception; Psychomotor Performance; Reaction Time; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sensory System Agents | 2010 |
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis.
Topics: Adult; Arachidonic Acids; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Endocannabinoids; Female; Humans; Lymphocytes; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Pain; Plant Extracts; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reflex, Stretch; Treatment Outcome; Young Adult | 2009 |
Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy: depression is a major confounding factor.
Topics: Adult; Aged; Cannabidiol; Depression; Diabetic Neuropathies; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Placebos; Plant Extracts; Quality of Life; Treatment Outcome | 2010 |
Lack of effect of central nervous system-active doses of nabilone on capsaicin-induced pain and hyperalgesia.
Topics: Adult; Capsaicin; Central Nervous System; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Humans; Male; Middle Aged; Pain; Pain Measurement; Treatment Outcome; Young Adult | 2012 |
Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
Topics: Adolescent; Adult; Analgesics, Non-Narcotic; Central Nervous System; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Heart Rate; Humans; Male; Pain; Pain Measurement; Postural Balance; Young Adult | 2012 |
Multiple sclerosis and extract of cannabis: results of the MUSEC trial.
Topics: Adolescent; Adult; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Muscle Tonus; Pain; Phytotherapy; Plant Extracts; Self Report; Severity of Illness Index; Sleep; Walking | 2012 |
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Cannabidiol; Cannabis; Cross-Over Studies; Double-Blind Method; Dronabinol; Humans; Hypotension; Muscle Spasticity; Nervous System Diseases; Pain; Phytotherapy; Placebos; Plant Preparations; Severity of Illness Index; Spasm; Urination Disorders | 2003 |
The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions.
Topics: Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Cold Temperature; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Female; Hot Temperature; Humans; Male; Morphine; Pain; Pain Threshold; Palliative Care; Pressure; Transcutaneous Electric Nerve Stimulation | 2003 |
Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.
Topics: Adult; Analgesics, Non-Narcotic; Chronic Disease; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Hyperalgesia; Male; Middle Aged; Pain; Pain Measurement | 2003 |
Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies.
Topics: Administration, Sublingual; Adult; Aged; Analgesics, Non-Narcotic; Cannabidiol; Chronic Disease; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Pain; Pain Measurement; Patient Selection; Sleep; Treatment Outcome | 2004 |
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.
Topics: Administration, Oral; Adult; Analgesics, Non-Narcotic; Cannabinoids; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Pain; Treatment Outcome | 2004 |
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients.
Topics: Aerosols; Cannabidiol; Cannabis; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Humans; Mouth Mucosa; Multiple Sclerosis; Muscle Spasticity; Pain; Pain Measurement; Plant Extracts; Tremor; Urinary Bladder Diseases | 2004 |
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Brachial Plexus Neuropathies; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Plant Extracts; Retrospective Studies; Sleep; Time Factors; Treatment Outcome | 2004 |
The effect of nabilone on neuropsychological functions related to driving ability: an extended case series.
Topics: Adult; Aged; Antiemetics; Attention; Automobile Driving; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Male; Memory, Short-Term; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Pain; Prospective Studies; Psychomotor Performance; Reaction Time | 2005 |
[Effect of the synthetic cannabinoid dronabinol on central pain in patients with multiple sclerosis--secondary publication].
Topics: Administration, Oral; Adult; Analgesics, Non-Narcotic; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Pain; Pain Measurement; Treatment Outcome | 2005 |
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.
Topics: Administration, Oral; Analgesics; Arthritis, Rheumatoid; Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Plant Extracts; Treatment Outcome | 2006 |
Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine.
Topics: Adolescent; Adult; Analgesics; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Synergism; Female; Hot Temperature; Humans; Injections, Intravenous; Male; Middle Aged; Morphine; Pain; Pain Measurement | 2006 |
Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
Topics: Adult; Age Factors; Aged; Amphetamines; Chronic Disease; Cocaine; Confidence Intervals; Dronabinol; Drug Prescriptions; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Narcotics; Pain; Pain Clinics; Prevalence; Prospective Studies; Substance Abuse Detection; Substance-Related Disorders; United States | 2006 |
[Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain--a randomized controlled trial].
Topics: Anti-Anxiety Agents; Cannabinoids; Chemotherapy, Adjuvant; Chronic Disease; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Placebo Effect; Quality of Life; Treatment Outcome | 2006 |
Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial.
Topics: Activities of Daily Living; Adolescent; Adult; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Motor Neuron Disease; Muscle Spasticity; Pain; Pain Measurement; Recurrence | 2006 |
The treatment of spasticity with Delta9-tetrahydrocannabinol in persons with spinal cord injury.
Topics: Administration, Oral; Administration, Rectal; Adult; Affect; Aged; Attention; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Exercise Test; Female; Humans; Lung; Male; Manometry; Middle Aged; Muscle Spasticity; Neuropsychological Tests; Pain; Spinal Cord Injuries; Treatment Outcome; Urinary Bladder | 2007 |
Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study.
Topics: Adult; Cannabinoid Receptor Agonists; Colon; Compliance; Dronabinol; Fasting; Female; Gastrointestinal Transit; Humans; Male; Pain; Sensory Thresholds | 2007 |
Nabilone for the treatment of pain in fibromyalgia.
Topics: Analgesics; Anxiety; Double-Blind Method; Dronabinol; Fibromyalgia; Humans; Middle Aged; Pain; Pain Measurement; Placebos; Quality of Life; Treatment Outcome | 2008 |
Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Topics: Administration, Oral; Administration, Sublingual; Adult; Aerosols; Analgesics, Opioid; Cannabidiol; Central Nervous System Diseases; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth Mucosa; Multiple Sclerosis; Pain; Plant Extracts | 2007 |
Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
Topics: Adult; Analgesics, Non-Narcotic; Cannabinoids; Cannabis; Capsaicin; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Hyperalgesia; Male; Marijuana Smoking; Neuropsychological Tests; Pain; Pain Measurement; Reference Values; Sensory System Agents; Sensory Thresholds; Time Factors | 2007 |
Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Chronic Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Pain; Pain Measurement | 2008 |
Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Codeine; Cross-Over Studies; Double-Blind Method; Dronabinol; Humans; Middle Aged; Pain; Treatment Outcome | 2008 |
Analgesic and antihyperalgesic effects of nabilone on experimental heat pain.
Topics: Adolescent; Adult; Analgesics; Anti-Anxiety Agents; Cannabinoids; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Hot Temperature; Humans; Hyperalgesia; Male; Pain | 2008 |
The analgesic properties of delta-9-tetrahydrocannabinol and codeine.
Topics: Analgesics; Aspirin; Cannabis; Clinical Trials as Topic; Codeine; Dextropropoxyphene; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Pain; Palliative Care; Phytotherapy; Placebos | 1975 |
Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain.
Topics: Analgesics; Clinical Trials as Topic; Codeine; Double-Blind Method; Dronabinol; Humans; Neoplasms; Pain; Secobarbital | 1978 |
Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response.
Topics: Adolescent; Adult; Analgesics; Anxiety; Diazepam; Dronabinol; Heart Rate; Humans; Injections, Intravenous; Male; Pain; Personality Inventory; Placebos; Sensory Receptor Cells | 1977 |
Effects of delta9-tetrahydrocannabinol and cannabinol in man.
Topics: Administration, Oral; Adult; Body Temperature; Cannabis; Dronabinol; Drug Interactions; Heart Rate; Humans; Male; Pain; Phytotherapy; Placebos; Pulse; Reaction Time | 1975 |
Marijuana: CNS depressant of excitant?
Topics: Adult; Arousal; Brain; Cannabis; Contingent Negative Variation; Depression, Chemical; Differential Threshold; Dronabinol; Electric Stimulation; Flicker Fusion; Humans; Male; Pain; Photic Stimulation; Placebos; Stimulation, Chemical; Substance-Related Disorders; Touch | 1974 |
119 other study(ies) available for dronabinol and Pain
| Article | Year |
|---|---|
A cannabinoid derived prototypical analgesic.
Topics: Analgesics; Animals; Cannabinoids; Cyclohexanols; Dogs; Drug Evaluation, Preclinical; Indicators and Reagents; Magnetic Resonance Spectroscopy; Mice; Models, Molecular; Pain; Rats; Spectrophotometry, Infrared; Structure-Activity Relationship | 1984 |
γ-Carbolines: a novel class of cannabinoid agonists with high aqueous solubility and restricted CNS penetration.
Topics: Analgesics; Animals; Brain; Cannabinoids; Carbolines; Cell Line; Drug Stability; Humans; Molecular Structure; Pain; Rats; Solubility | 2012 |
Ensemble-based virtual screening for cannabinoid-like potentiators of the human glycine receptor α1 for the treatment of pain.
Topics: Analgesics, Non-Narcotic; Animals; Binding Sites; Cannabinoids; Drug Evaluation, Preclinical; Female; Lipids; Molecular Dynamics Simulation; Molecular Targeted Therapy; Nuclear Magnetic Resonance, Biomolecular; Oocytes; Pain; Protein Conformation; Protein Structure, Tertiary; Receptors, Glycine; Reproducibility of Results; Xenopus laevis | 2015 |
Cannabinoids for the treatment of refractory neuropathic pruritus in amyotrophic lateral sclerosis: A case report.
Topics: Amyotrophic Lateral Sclerosis; Cannabinoids; Dronabinol; Humans; Middle Aged; Pain; Pruritus | 2022 |
No antinociceptive synergy between morphine and delta-9-tetrahydrocannabinol in male and female rats with persistent inflammatory pain.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Female; Freund's Adjuvant; Hyperalgesia; Inflammation; Locomotion; Male; Morphine; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Sex Factors | 2021 |
Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Catalepsy; Dronabinol; Female; Male; Pain; Rats; Rats, Sprague-Dawley | 2022 |
Adolescent THC exposure: effects on pain-related, exploratory, and consummatory behaviors in adult male vs. female rats.
Topics: Analgesics; Animals; Consummatory Behavior; Dopamine; Dronabinol; Female; Male; Pain; Rats | 2022 |
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome'.
Topics: Cannabidiol; Central Nervous System Diseases; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Cramp; Muscle Spasticity; Pain; Spasm; Treatment Outcome | 2022 |
In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center.
Topics: Analgesics; Cannabinoids; Cannabis; Dronabinol; Drug-Related Side Effects and Adverse Reactions; Humans; Medical Marijuana; Neoplasms; Pain; Retrospective Studies | 2022 |
Sex differences exist in the perceived relief of cancer symptoms with medical cannabis: results from the Quebec Cannabis Registry.
Topics: Analgesics; Cannabidiol; Cannabis; Dronabinol; Fatigue; Female; Humans; Male; Medical Marijuana; Nausea; Neoplasms; Pain; Quebec; Registries | 2022 |
Assessing Efficacy and Use Patterns of Medical Cannabis for Symptom Management in Elderly Cancer Patients.
Topics: Aged; Cannabidiol; Cannabis; Dronabinol; Humans; Medical Marijuana; Nausea; Neoplasms; Pain; Retrospective Studies; Sleep Initiation and Maintenance Disorders | 2023 |
Analgesia by intrathecal delta-9-tetrahydrocannabinol is dependent on Cav3.2 calcium channels.
Topics: Analgesia; Analgesics; Animals; Calcium Channels, T-Type; Dronabinol; Female; Hyperalgesia; Male; Mice; Pain; Receptors, Cannabinoid; Spinal Cord Dorsal Horn | 2023 |
Novel GPR18 Ligands in Rodent Pharmacological Tests: Effects on Mood, Pain, and Eating Disorders.
Topics: Animals; Dose-Response Relationship, Drug; Dronabinol; Feeding and Eating Disorders; Ligands; Male; Mice; Pain; Rats; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Rodentia | 2023 |
Cannabis-based products and multiple sclerosis-related pain: The role of routes of administration.
Topics: Cannabis; Dronabinol; Humans; Multiple Sclerosis; Pain | 2023 |
Unlocking the Healing Potential: Cannabinoids in Spine Surgery for Pain Relief and Recovery.
Topics: Cannabinoids; Cannabis; Dronabinol; Humans; Pain; Pain Management | 2023 |
[High-dose dronabinol treatment vs. medicinal cannabis flowers].
Topics: Adult; Chronic Disease; Dronabinol; Flowers; Humans; Insurance, Health; Low Back Pain; Medical Marijuana; Pain; Treatment Outcome | 2019 |
Reduced urinary opioid levels from pain management patients associated with marijuana use.
Topics: Analgesics, Opioid; Dronabinol; Humans; Marijuana Use; Pain; Pain Management; Retrospective Studies | 2019 |
The effectiveness of self-directed medical cannabis treatment for pain.
Topics: Analgesics; Cannabidiol; Cannabis; Dronabinol; Drug-Related Side Effects and Adverse Reactions; Flowers; Humans; Medical Marijuana; Pain | 2019 |
Repeated Vaginal Exposures to the Common Cosmetic and Household Preservative Methylisothiazolinone Induce Persistent, Mast Cell-Dependent Genital Pain in ND4 Mice.
Topics: Allergens; Animals; Cosmetics; Dermatitis, Allergic Contact; Dronabinol; Female; Humans; Immunoglobulin E; Mast Cells; Mice; Mucous Membrane; Pain; Preservatives, Pharmaceutical; Skin; Thiazoles; Vagina | 2019 |
Disease-modifying effects of natural Δ9-tetrahydrocannabinol in endometriosis-associated pain.
Topics: Analgesics, Non-Narcotic; Animals; Dronabinol; Endometriosis; Female; Mice, Inbred C57BL; Pain; Pain Management; Random Allocation | 2020 |
Tetrahydrocannabinol and Cannabidiol Use in an Outpatient Palliative Medicine Population.
Topics: Adult; Aged; Aged, 80 and over; Cannabidiol; Cross-Sectional Studies; Dronabinol; Drug Administration Routes; Florida; Humans; Medical Marijuana; Middle Aged; Pain; Palliative Care; Practice Patterns, Physicians' | 2020 |
Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.
Topics: Adolescent; Adult; Cannabidiol; Cannabis; Cohort Studies; Dronabinol; Female; Hallucinogens; Humans; Longitudinal Studies; Los Angeles; Male; Marijuana Use; Pain; Self Report; Substance-Related Disorders; Young Adult | 2021 |
Modulation of Recombinant Human T-Type Calcium Channels by Δ
Topics: Calcium Channels, T-Type; Dronabinol; HEK293 Cells; Humans; Pain | 2022 |
Vapor exposure to Δ9-tetrahydrocannabinol (THC) slows locomotion of the Maine lobster (Homarus americanus).
Topics: Administration, Inhalation; Animals; Cooking; Dronabinol; E-Cigarette Vapor; Electronic Nicotine Delivery Systems; Female; Hot Temperature; Locomotion; Maine; Male; Marijuana Smoking; Nephropidae; Nociception; Pain; Rats | 2021 |
Antinociceptive effects of JWH015 in female and male rats.
Topics: Analgesics; Animals; Camphanes; Cannabinoid Receptor Agonists; Dronabinol; Female; Freund's Adjuvant; Indoles; Male; Pain; Pain Measurement; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Sex Factors | 2018 |
Comparison of cannabinoids with known analgesics using a novel high throughput zebrafish larval model of nociception.
Topics: Acetaminophen; Acetic Acid; Analgesics; Animals; Cannabinoid Receptor Agonists; Cannabinoids; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Ibuprofen; Larva; Locomotion; Nociception; Pain; Principal Component Analysis; Time Factors; Tramadol; Zebrafish | 2018 |
Sex differences in antinociceptive response to Δ-9-tetrahydrocannabinol and CP 55,940 in the mouse formalin test.
Topics: Analgesics; Analysis of Variance; Animals; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Female; Formaldehyde; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Pain; Pain Measurement; Receptor, Cannabinoid, CB1; Sex Characteristics; Time Factors; Treatment Outcome | 2018 |
Medication overuse headache following repeated morphine, but not [INCREMENT]9-tetrahydrocannabinol administration in the female rat.
Topics: Analgesics, Opioid; Animals; Dronabinol; Drug Tolerance; Dura Mater; Female; Headache Disorders, Secondary; Injections, Intraperitoneal; Isothiocyanates; Migraine Disorders; Models, Animal; Morphine; Motor Activity; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley | 2018 |
Effect of cannabidiolic acid and ∆
Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Cannabinoids; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Edema; Hyperalgesia; Inflammation; Male; Pain; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2018 |
Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases.
Topics: Administration, Sublingual; Adult; Analgesics, Opioid; Cannabidiol; Cannabis; Dronabinol; Drug Combinations; Drug Therapy, Combination; Epidermolysis Bullosa; Female; Humans; Male; Middle Aged; Netherlands; Pain; Pain Measurement; Plant Oils; Treatment Outcome | 2019 |
Time to drop the stigma: cannabinoids are drugs that may alleviate pain in people with epidermolysis bullosa.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Epidermolysis Bullosa; Humans; Pain | 2019 |
Age-related differences in Δ⁹-tetrahydrocannabinol-induced antinociception in female and male rats.
Topics: Analgesics; Animals; Cannabinol; Cannabis; Dronabinol; Female; Locomotion; Male; Motor Activity; Pain; Pain Measurement; Rats; Sex Characteristics | 2019 |
Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms.
Topics: Adolescent; Adult; Aged; Anorexia; Canada; Cannabidiol; Dronabinol; Female; Humans; Male; Mental Disorders; Middle Aged; Mobile Applications; Pain; Palliative Care; Patient Portals; Patient Satisfaction; Retrospective Studies; Sleep Initiation and Maintenance Disorders | 2019 |
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis.
Topics: Adult; Aged; Analgesics, Non-Narcotic; Cannabidiol; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Pain; Retrospective Studies; Treatment Outcome | 2014 |
[Therapeutic use of cannabis derivatives].
Topics: Antiemetics; Cannabidiol; Dronabinol; Drug Combinations; Fibromyalgia; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Plant Extracts | 2014 |
THC may reproducibly induce electrical hyperalgesia in healthy volunteers.
Topics: Adult; Dronabinol; Female; Healthy Volunteers; Humans; Hyperalgesia; Pain; Pain Threshold; Young Adult | 2015 |
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.
Topics: Animals; Body Temperature Regulation; CA1 Region, Hippocampal; CA2 Region, Hippocampal; CA3 Region, Hippocampal; Cannabinoid Receptor Agonists; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Enteric Nervous System; Gastrointestinal Motility; Hypothermia; Intestinal Mucosa; Intestines; Ligands; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Pain; Pain Threshold; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Stress, Psychological; Time Factors | 2015 |
Medical use of cannabis products: Lessons to be learned from Israel and Canada.
Topics: Canada; Cannabidiol; Cross-Cultural Comparison; Dronabinol; Drug and Narcotic Control; Drug Combinations; Germany; Humans; Insurance Coverage; Israel; Medical Marijuana; National Health Programs; Pain | 2016 |
[Cannabis as a therapeutic agent: Focal topic].
Topics: Cannabidiol; Combined Modality Therapy; Dronabinol; Germany; Insurance Coverage; Medical Marijuana; National Health Programs; Pain; Palliative Care; Prescription Drugs | 2016 |
Pro-drugs for indirect cannabinoids as therapeutic agents.
Topics: Acetaminophen; Amidohydrolases; Animals; Arachidonic Acids; Cannabinoids; Dronabinol; Humans; Pain; Prodrugs | 2008 |
Willingness to pay for a treatment for pain in multiple sclerosis.
Topics: Administration, Oral; Administration, Sublingual; Adult; Aerosols; Aged; Aged, 80 and over; Analgesics, Opioid; Attitude to Health; Cannabidiol; Cost-Benefit Analysis; Decision Making; Dronabinol; Drug Combinations; Fees and Charges; Female; Humans; Insurance, Health; Interviews as Topic; Male; Middle Aged; Multiple Sclerosis; Pain; Patient Satisfaction; Plant Extracts; Surveys and Questionnaires | 2009 |
Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
Topics: Acetic Acid; Analgesics; Animals; Anti-Obesity Agents; Camphanes; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Male; Mice; Mice, Inbred ICR; Motor Activity; Pain; Pain Measurement; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; RNA, Messenger | 2009 |
Cannabis derivatives and pain. A small role for delta9-tetrahydrocannabinol (THC) in some forms of multiple sclerosis.
Topics: Administration, Oral; Administration, Sublingual; Cannabinoids; Cannabis; Dronabinol; Humans; Marijuana Smoking; Meta-Analysis as Topic; Multiple Sclerosis; Neuralgia; Pain; Phytotherapy; Plant Preparations; Randomized Controlled Trials as Topic | 2009 |
Antinociceptive activity of Delta9-tetrahydrocannabinol non-ionic microemulsions.
Topics: Administration, Oral; Analgesics; Animals; Chemistry, Pharmaceutical; Disease Models, Animal; Dronabinol; Drug Compounding; Drug Stability; Emulsions; Injections, Intraperitoneal; Male; Mice; Pain; Pain Measurement; Pain Threshold; Polyethylene Glycols; Reaction Time; Solubility; Stearic Acids; Surface-Active Agents; Technology, Pharmaceutical; Temperature; Time Factors | 2010 |
Medical marijuana and the mind. More is known about the psychiatric risks than the benefits.
Topics: Administration, Inhalation; Administration, Oral; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Health Knowledge, Attitudes, Practice; Humans; Marijuana Smoking; Nausea; Pain; Phytotherapy; Plant Preparations; Psychoses, Substance-Induced; United States | 2010 |
The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice.
Topics: Animals; Cell Line, Transformed; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dose-Response Relationship, Drug; Dronabinol; Edema; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Inflammation; Male; Membranes; Mice; Mice, Inbred C57BL; Pain; Pain Measurement; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Spleen | 2010 |
Antinociception and sedation following intracerebroventricular administration of Δ⁹-tetrahydrocannabinol in female vs. male rats.
Topics: Analgesia; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Dronabinol; Estrous Cycle; Female; Hot Temperature; Male; Motor Activity; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Sex Characteristics | 2011 |
[Cannabis medicinal drugs. "Psychedelics" by prescription?].
Topics: Cannabidiol; Cannabis; Dronabinol; Drug Approval; Drug Combinations; Germany; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Palliative Care; Phytotherapy; Plant Extracts; Psychoses, Substance-Induced | 2010 |
CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Female; Histamine H1 Antagonists; Hypersensitivity; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Loratadine; Male; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Pain; Piperidines; Pruritus; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2011 |
Oral fluid testing: promises and pitfalls.
Topics: Analgesics; Automobile Driving; Chromatography, Liquid; Dronabinol; Humans; Immunoassay; Marijuana Abuse; Pain; Psychotropic Drugs; Saliva; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry; Workplace | 2011 |
Receptors: cannabis medicine without a high.
Topics: Analgesics, Non-Narcotic; Brain; Cannabis; Dronabinol; Humans; Pain; Receptors, Glycine | 2011 |
THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Discrimination Learning; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Locomotion; Male; Methadone; Naltrexone; Narcotic Antagonists; Pain; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu | 2011 |
Medical marijuana use and suicide attempt in a patient with major depressive disorder.
Topics: Adult; Chronic Disease; Colorado; Depressive Disorder, Major; Dronabinol; Drug and Narcotic Control; Drug Approval; Ethylene Glycol; Female; Humans; Marijuana Abuse; Marijuana Smoking; Pain; Prescription Drugs; Risk Factors; Suicide, Attempted | 2011 |
New pain drugs in pipeline, but challenges to usage remain.
Topics: Analgesics; Analgesics, Opioid; Antineoplastic Agents; Cannabidiol; Cannabinoids; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drugs, Investigational; Humans; Neoplasms; Neuralgia; Pain; Palliative Care; Plant Extracts | 2012 |
Nabilone in inflammatory pain: to be or not to be.
Topics: Capsaicin; Central Nervous System; Dronabinol; Humans; Male; Pain; Pain Measurement | 2012 |
Severe cannabinoid intoxication in a patient with non-small-cell lung cancer.
Topics: Analgesics, Non-Narcotic; Cannabis; Carcinoma, Non-Small-Cell Lung; Coma; Dronabinol; Female; Humans; Lung Neoplasms; Middle Aged; Pain; Phytotherapy; Plant Extracts | 2012 |
[Mechanism of action of paracetamol--further contribution to discovery].
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Biotransformation; Calcium Channels; Dronabinol; Humans; Mice; Nerve Tissue Proteins; Neurotransmitter Agents; Pain; Rats; Receptors, N-Methyl-D-Aspartate; Sodium Channels; Synapses; Transient Receptor Potential Channels; TRPA1 Cation Channel | 2012 |
Dissociable effects of the cannabinoid receptor agonists Δ9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Brain; Cannabinoid Receptor Agonists; Conditioning, Operant; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Eating; Electrodes, Implanted; Ketoprofen; Lactic Acid; Male; Pain; Rats; Rats, Sprague-Dawley; Self Stimulation | 2012 |
Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptor
Topics: Analgesics; Animals; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Cerebral Ventricles; Cimetidine; Dronabinol; Endocannabinoids; Hot Temperature; Injections, Intraventricular; Male; Mice; Pain; Piperidines; Pyrazoles; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Time Factors | 2002 |
Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Aspirin; Camphanes; Diclofenac; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Ethanolamines; Indomethacin; Kinetics; Male; Mice; Mice, Inbred ICR; Pain; Polyunsaturated Alkamides; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug | 2002 |
Dynorphin-independent spinal cannabinoid antinociception.
Topics: Analgesics; Analgesics, Non-Narcotic; Animals; Benzoxazines; Dose-Response Relationship, Drug; Dronabinol; Dynorphins; Injections, Spinal; Male; Mice; Mice, Knockout; Morpholines; Naltrexone; Naphthalenes; Pain; Pain Measurement; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Species Specificity; Spinal Cord | 2002 |
[Therapy of severe pain. Cannabinoid acts not only as an analgesic].
Topics: Analgesics, Non-Narcotic; Dronabinol; Humans; Pain; Palliative Care; Quality of Life; Time Factors | 2002 |
[The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain].
Topics: Aged; Analgesics; Analgesics, Non-Narcotic; Anxiety; Data Interpretation, Statistical; Depression; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neuralgia; Pain; Pain Measurement; Pilot Projects; Polyneuropathies; Quality of Life; Surveys and Questionnaires | 2002 |
Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration.
Topics: Administration, Oral; Analgesics; Animals; Codeine; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Drug Therapy, Combination; Male; Mice; Mice, Inbred ICR; Morphine; Narcotics; Pain | 2003 |
Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cannabinoid Receptor Agonists; Disinfectants; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Escape Reaction; Excitatory Amino Acid Antagonists; Formaldehyde; Homocysteine; Immunohistochemistry; Male; Microinjections; Movement; Pain; Pain Measurement; Periaqueductal Gray; Piperidines; Proto-Oncogene Proteins c-fos; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Time Factors | 2003 |
Treatment of chronic intractable neuropathic pain with dronabinol: case report of two adolescents.
Topics: Adolescent; Analgesics, Non-Narcotic; Chronic Disease; Dronabinol; Female; Humans; Male; Pain; Pain Measurement; Treatment Outcome | 2003 |
Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain.
Topics: Animals; Behavior, Animal; Biogenic Monoamines; Body Temperature; Brain; Brain Chemistry; Cannabidiol; Chromatography, High Pressure Liquid; Corticosterone; Disease Models, Animal; Dronabinol; Drug Interactions; Formaldehyde; Male; Morphine; Motor Activity; Narcotics; Pain; Pain Measurement; Psychotropic Drugs; Radioimmunoassay; Rats; Time Factors | 2004 |
The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat.
Topics: Animals; Arthritis, Experimental; Cannabinoid Receptor Antagonists; Dose-Response Relationship, Drug; Dronabinol; Dynorphins; Enkephalin, Leucine; Enkephalin, Methionine; Freund's Adjuvant; Injections, Intradermal; Injections, Intraperitoneal; Male; Morphine; Mycobacterium; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Opioid; Rimonabant | 2004 |
Medicinal cannabis extracts for the treatment of multiple sclerosis.
Topics: Animals; Cannabis; Chronic Disease; Clinical Trials, Phase III as Topic; Dronabinol; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Phytotherapy; Plant Extracts; Randomized Controlled Trials as Topic | 2004 |
Pain reduction and lack of psychotropic effects with ajulemic acid: comment on the article by Sumariwalla et al.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cannabidiol; Clinical Trials, Phase I as Topic; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dronabinol; Humans; Pain; Psychotropic Drugs | 2004 |
The brain's own marijuana.
Topics: Animals; Anxiety; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Cannabis; Dronabinol; Humans; Nausea; Neurotransmitter Agents; Obesity; Opium; Pain; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Signal Transduction | 2004 |
Pain killer without a high.
Topics: Animals; beta-Endorphin; Dronabinol; Humans; Keratinocytes; Mice; Pain; Rats; Receptor, Cannabinoid, CB2 | 2005 |
Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat.
Topics: Analgesics; Animals; Benzoxazines; Cannabinoids; Catalepsy; Cell Line; Chromatography; Cricetinae; Cricetulus; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Freund's Adjuvant; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hypothermia; Inflammation; Ligation; Male; Morpholines; Motor Activity; Naphthalenes; Pain; Pain Measurement; Pain Threshold; Radioligand Assay; Rats; Rats, Wistar; Rotarod Performance Test; Sciatic Neuropathy; Sulfur Isotopes; Time Factors; Tritium | 2005 |
Sativex for the management of multiple sclerosis symptoms.
Topics: Administration, Oral; Administration, Sublingual; Aerosols; Analgesics; Canada; Cannabidiol; Dronabinol; Drug Approval; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Phytotherapy; Plant Extracts; Randomized Controlled Trials as Topic; Sleep Wake Disorders; Tremor; United Kingdom | 2005 |
The use of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.
Topics: Analgesics; Arthritis, Rheumatoid; Cannabidiol; Cannabis; Dronabinol; Drug Combinations; Humans; Pain; Plant Extracts; Treatment Outcome | 2006 |
Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief.
Topics: Adult; Analgesics, Non-Narcotic; Axons; Dronabinol; Female; Fibromyalgia; Humans; Male; Neural Conduction; Pain; Pilot Projects; Psychometrics; Reflex; Vasodilation | 2006 |
Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
Topics: Acetaminophen; Amides; Analgesics; Animals; Arachidonic Acids; Benzamides; Benzoquinones; Camphanes; Capsaicin; Carbamates; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Ethanolamines; Hyperalgesia; Male; Mesencephalon; Mice; Mice, Inbred ICR; Narcotic Antagonists; Pain; Palmitic Acids; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid; Rimonabant; Spinal Cord; TRPV Cation Channels | 2006 |
Cannabinoid-improgan cross-tolerance: Improgan is a cannabinomimetic analgesic lacking affinity at the cannabinoid CB1 receptor.
Topics: Analgesics; Analysis of Variance; Animals; Benzoxazines; Binding, Competitive; Cannabinoids; Cimetidine; Dronabinol; Drug Tolerance; Injections, Intraventricular; Injections, Subcutaneous; Male; Mice; Morpholines; Naphthalenes; Pain; Pain Measurement; Receptor, Cannabinoid, CB1; Time Factors | 2006 |
New pain management options: drugs.
Topics: Analgesics, Opioid; Cannabidiol; Cannabinoids; Carbazoles; Chronic Disease; Dronabinol; Drug Combinations; Humans; Ibuprofen; Oxycodone; Oxymorphone; Pain; Plant Extracts; Serotonin Receptor Agonists; Tryptamines | 2007 |
Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis.
Topics: Acute Disease; Animals; Biopsy; Cannabinoid Receptor Modulators; Cannabinoids; Ceruletide; Dronabinol; Female; Gene Expression Regulation; Humans; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Pain; Pancreas; Pancreatitis; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2007 |
The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.
Topics: Analgesics; Animals; Arthritis, Experimental; Camphanes; Dronabinol; Male; Mesencephalon; Pain; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Spinal Cord | 2007 |
Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Benzoxazines; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Drug Therapy, Combination; Drug Tolerance; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Guanosine 5'-O-(3-Thiotriphosphate); Injections, Intraperitoneal; Injections, Subcutaneous; Male; Morphine; Morpholines; Naphthalenes; Pain; Pain Measurement; Pain Threshold; Periaqueductal Gray; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Opioid, mu; Spinal Cord; Sulfur Radioisotopes; Time Factors | 2007 |
Cannabis; adverse effects from an oromucosal spray.
Topics: Administration, Oral; Adult; Aerosols; Aged; Burns, Chemical; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth Mucosa; Multiple Sclerosis; Pain; Phytotherapy; Plant Extracts | 2007 |
Gonadal hormone modulation of the behavioral effects of Delta9-tetrahydrocannabinol in male and female rats.
Topics: Analgesics, Non-Narcotic; Animals; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Estradiol; Estrous Cycle; Female; Male; Motor Activity; Orchiectomy; Ovariectomy; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Sex Factors; Testosterone | 2008 |
[What sense in cannabinoid use as regulated by Italian DM 18/04/07? Pharmacological and legal considerations].
Topics: Analgesics, Non-Narcotic; Dronabinol; Drug and Narcotic Control; Drug Labeling; Drug Prescriptions; Italy; Pain | 2008 |
Tonic analgesic effects of delta 9-tetrahydrocannabinol as measured with the formalin test.
Topics: Analgesics; Animals; Body Temperature; Dronabinol; Female; Formaldehyde; Male; Pain; Rats; Time Factors | 1980 |
Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol.
Topics: Amphetamine; Analgesia; Animals; Anticonvulsants; Apomorphine; Behavior, Animal; Body Temperature; Cyclohexanols; Dogs; Dronabinol; Drug Interactions; Male; Mice; Motor Activity; Pain; Tetrabenazine; Vocalization, Animal | 1982 |
Cannabis as a medicine?
Topics: Animals; Cannabis; Dronabinol; Female; Fetal Growth Retardation; Humans; Nausea; Pain; Pregnancy; Schizophrenia; Vomiting | 1995 |
Antisense oligodeoxynucleotides to the kappa-1 receptor block the antinociceptive effects of delta 9-THC in the spinal cord.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Base Sequence; Dronabinol; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Mice; Mice, Inbred ICR; Molecular Sequence Data; Oligonucleotides, Antisense; Pain; Psychotropic Drugs; Pyrrolidines; Receptors, Opioid, kappa; Spinal Cord | 1995 |
Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.
Topics: Animals; Body Temperature Regulation; Cannabinoids; Catalepsy; Cyclohexanols; Dronabinol; Male; Maze Learning; Mice; Mice, Inbred ICR; Motor Activity; Nitrogen Mustard Compounds; Pain; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship | 1996 |
Analgesic effects of 1',1' dimethylheptyl-delta8-THC-11-oic acid (CT3) in mice.
Topics: Analgesics; Animals; Dronabinol; Male; Mice; Pain; Platelet Aggregation | 1998 |
Synthesis and pharmacology of the isomeric methylheptyl-delta8-tetrahydrocannabinols.
Topics: Animals; Body Temperature; Brain; Cannabinoids; Dronabinol; Indicators and Reagents; Isomerism; Mice; Molecular Conformation; Molecular Structure; Motor Activity; Pain; Receptors, Cannabinoid; Receptors, Drug; Resorcinols; Structure-Activity Relationship | 1998 |
Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors.
Topics: Analgesics; Dronabinol; Humans; Multiple Sclerosis; Naloxone; Narcotic Antagonists; Pain; Pain Measurement; Receptors, Opioid | 1999 |
Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception.
Topics: Analgesics; Animals; Cannabinoids; Cyclohexanols; Dimethyl Sulfoxide; Dronabinol; Dynorphins; Injections, Spinal; Male; Naltrexone; Narcotic Antagonists; Nociceptors; Pain; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant | 1999 |
Dopamine D(2) receptor antagonists prevent delta(9)-tetrahydrocannabinol-induced antinociception in rats.
Topics: Analgesics, Non-Narcotic; Animals; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dronabinol; Male; Nociceptors; Pain; Piperidines; Pyrazoles; Quinpirole; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Rimonabant; Sulpiride | 1999 |
Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide.
Topics: Analgesia; Analgesics; Analgesics, Non-Narcotic; Animals; Arachidonic Acids; Calcium Channel Blockers; Cannabinoid Receptor Modulators; Cannabinoids; Cyclohexanols; Dronabinol; Dynorphins; Endocannabinoids; Endorphins; Male; Pain; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Spinal Cord | 2000 |
Antinociceptive effects of tetrahydrocannabinol side chain analogs: dependence upon route of administration.
Topics: Analgesics, Non-Narcotic; Animals; Dronabinol; Drug Administration Routes; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Nociceptors; Pain; Pain Measurement; Structure-Activity Relationship | 2000 |
Pharmacological evaluation of aerosolized cannabinoids in mice.
Topics: Administration, Inhalation; Aerosols; Animals; Cannabinoids; Dose-Response Relationship, Drug; Dronabinol; Hallucinogens; Injections, Intravenous; Male; Mice; Mice, Inbred ICR; Pain; Piperidines; Pyrazoles; Rimonabant | 2000 |
HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test.
Topics: Analgesics, Opioid; Animals; Cannabinoid Receptor Modulators; Cannabinoids; Dinoprostone; Dose-Response Relationship, Drug; Dronabinol; Injections, Spinal; Male; Mice; Mice, Inbred C57BL; Morphine; Pain; Pain Measurement; Receptors, Cannabinoid; Receptors, Drug | 2001 |
Fatty acid amide hydrolase inhibitors and the marijuana debate.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Brain; Dronabinol; Endocannabinoids; Humans; Mice; Pain; Polyunsaturated Alkamides | 2001 |
[Tetrahydrocannabinol for treatment of chronic pain].
Topics: Adult; Aged; Analgesics, Non-Narcotic; Chronic Disease; Dronabinol; Female; Humans; Male; Middle Aged; Pain; Reproducibility of Results; Retrospective Studies | 2001 |
Cannabinoids and brain injury: therapeutic implications.
Topics: Animals; Arachidonic Acids; Brain; Brain Injuries; Cannabinoid Receptor Modulators; Cannabinoids; Clinical Trials, Phase III as Topic; Dronabinol; Endocannabinoids; Glycerides; Humans; Neuroprotective Agents; Pain; Polyunsaturated Alkamides; Rats | 2002 |
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
Topics: Acute Disease; Animals; Camphanes; Cannabinoids; Carrageenan; Dronabinol; Hypersensitivity; Indoles; Male; Morpholines; Neurogenic Inflammation; Nociceptors; Pain; Pyrazoles; Rats; Rats, Inbred Strains; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug | 2002 |
Delta 9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism.
Topics: Afferent Pathways; Animals; Biological Assay; Calcitonin Gene-Related Peptide; Calcium; Cannabinoids; Cannabinol; Capsaicin; Dose-Response Relationship, Drug; Dronabinol; Female; Hepatic Artery; In Vitro Techniques; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons, Afferent; Pain; Psychotropic Drugs; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Vasodilation | 2002 |
Interactions of thyrotropin releasing hormone and morphine sulfate in rodents.
Topics: Analgesics; Animals; Apomorphine; Behavior, Animal; Body Weight; Chlorpromazine; Dronabinol; Humans; Mice; Morphinans; Morphine; Pain; Pentobarbital; Rats; Substance Withdrawal Syndrome; Thyrotropin-Releasing Hormone | 1977 |
Potential therapeutic applications of naturally occurring and synthetic cannabinoids.
Topics: Alcoholism; Animals; Appetite; Asthma; Cannabinoids; Cough; Depression; Diarrhea; Dronabinol; Epilepsy; Glaucoma; Humans; Hypertension; Narcotics; Neoplasms; Pain; Parasympatholytics; Substance-Related Disorders; Vomiting | 1978 |
Marijuana. Does it have a possible therapeutic use?
Topics: Asthma; Cannabinoids; Cannabis; Depression; Dronabinol; Drug Stability; Epilepsy; Glaucoma; Humans; Pain; Vomiting | 1978 |
Marijuana and heroin by prescription? Recent developments at the state and federal levels.
Topics: Cannabis; Dronabinol; Drug Prescriptions; Heroin; Humans; Legislation, Drug; Pain; Research; United States; United States Food and Drug Administration | 1979 |
Letter: Tetrahydrocannabinol and chemotherapy.
Topics: Adult; Bone Neoplasms; Cannabis; Dronabinol; Female; Humans; Hyperalgesia; Hyperesthesia; Leukemia, Myeloid, Acute; Male; Pain; Phytotherapy; Vomiting | 1976 |
Emotional response to intravenous delta9tetrahydrocannabinol during oral surgery.
Topics: Adolescent; Adult; Anxiety; Cannabis; Diazepam; Dronabinol; Emotions; Hippocampus; Humans; Injections, Intravenous; Male; Mouth; Pain; Placebos; Psychological Tests; Psychoses, Substance-Induced; Retrospective Studies; Septum Pellucidum; Time Factors | 1976 |
Effect of cannabinoids on the abdominal constriction response in mice: within cannabinoid interactions.
Topics: Abdomen; Analgesia; Animals; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Female; Formates; Mice; Pain | 1976 |
Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia.
Topics: Analgesia; Analysis of Variance; Animals; Body Temperature; Body Temperature Regulation; Brain; Catalepsy; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Dronabinol; Injections, Intravenous; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Motor Activity; Pain; Spinal Cord; Tissue Distribution | 1992 |
Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties.
Topics: Animals; Behavior, Animal; Body Weight; Copper; Dronabinol; Drug Interactions; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Nervous System Diseases; Pain; Pain Measurement; Rats; Receptors, N-Methyl-D-Aspartate | 1991 |
Cannabinoids and pain responses: a possible role for prostaglandins.
Topics: Analgesia; Animals; Dose-Response Relationship, Drug; Dronabinol; Female; Hot Temperature; Hyperalgesia; Hyperesthesia; Indomethacin; Mice; Pain; Prostaglandins | 1988 |
Therapeutic issues of marijuana and THC (tetrahydrocannabinol).
Topics: Antineoplastic Agents; Anxiety; Bronchial Spasm; Cannabis; Dronabinol; Glaucoma; Humans; Muscle Spasticity; Nausea; Pain; Sleep Initiation and Maintenance Disorders; Vomiting | 1985 |
Effects of delta-1-tetrahydrocannabinol on Sidman discriminated avoidance behavior in rats.
Topics: Animals; Ataxia; Auditory Perception; Avoidance Learning; Cannabis; Conditioning, Operant; Cues; Depression, Chemical; Discrimination Learning; Dose-Response Relationship, Drug; Dronabinol; Exploratory Behavior; Grooming; Male; Pain; Rats; Visual Perception | 1974 |
Effects of delta9-tetrahydrocannabinol (THC) on several rodent learning paradigms.
Topics: Animals; Avoidance Learning; Behavior, Animal; Cannabis; Depression, Chemical; Drinking Behavior; Dronabinol; Electroshock; Fear; Learning; Male; Mice; Motor Activity; Pain; Rats; Reaction Time; Species Specificity; Stimulation, Chemical; Time Factors | 1973 |
Analgesic activity of 9 -tetrahydrocannabinol in the rat and mouse.
Topics: Analgesia; Analgesics; Animals; Cannabis; Dronabinol; Hot Temperature; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Mice, Inbred Strains; Morphine; Pain; Rats; Rats, Inbred Strains; Time Factors | 1972 |
Some pharmacological and toxicological effects of 1-trans- 8 and 1-trans- 9 -tetrahydrocannabinol in laboratory rodents.
Topics: Animals; Cannabis; Charcoal; Dronabinol; Drug Antagonism; Gastrointestinal Motility; Ileum; Intestine, Small; Jejunum; Kinetics; Lethal Dose 50; Male; Mice; Pain; Parasympathomimetics; Quaternary Ammonium Compounds; Rats; Reaction Time; Spasm; Stereoisomerism; Tail; Vas Deferens | 1972 |